Journal article Open Access

Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking Cessation

Kittakoop, Prasat; Mahidol, Chulabhorn; Ruchirawat, Somsak

Alkaloid molecules can act, depending on a type of amine functionality present in alkalods, as either hydrogen-acceptor or hydrogen-donor for hydrogen bonding that is critically important for the interaction (binding) between targets (enzymes, proteins and receptors) and drugs (ligands). Because of this unique property, alkaloid scaffolds are therefore present in several drugs and lead compounds. This review highlights alkaloid scaffolds in drugs, particularly those recently approved in 2012; it also covers the scaffolds in leads and drug candidates which are in clinical trials and preclinical pipeline. The review focuses on three therapeutic areas including treatments of cancer, tuberculosis, and tobacco cessation. Alkaloid scaffolds in drugs and leads are inspired by those of naturally occurring alkaloids, and these scaffolds include pyridine, piperidine, quinoline, quinolinone, quinazoline, isoquinoline, indole, indolinone, isoindole, isoxazole, imidazole, indazole, thiazole, pyrazole, oxazolidinone, oxadiazole, and benzazepine. In addition to medicinal chemistry aspects, natural products possessing an individual alkaloid scaffold, as well as the mechanism of action of drugs and leads, are also discussed in this review.
Files (972.9 kB)
Name Size
article.pdf
md5:76a11d36ed65e8538e68652f920c3459
972.9 kB Download
536
403
views
downloads
Views 536
Downloads 403
Data volume 392.1 MB
Unique views 508
Unique downloads 370

Share

Cite as